Related Diagnostic Codes ⁽¹⁾

The following ICD-9-CM Diagnostic Codes describe conditions that may apply to a dry eye diagnosis:

• 375.15 Tear Film Insufficiency, Unspecified; Dry Eye Syndrome
• 370.33 Keratoconjunctivitis sicca, not specified as Sjögren's syndrome
• 710.2   Sicca syndrome, keratoconjunctivitis sicca Sjögren's disease
• 365.11 Primary open angle glaucoma
• 373.12 Meibomian gland infection
• 373.71 Hyperemic conjunctiva
• 370.23 Filamentary keratitis
• 371.42 Recurrent corneal erosion
• 375.21 Epiphora excess lacrimation
• 375.22 Epiphora insufficient drainage
• 374.01 Entropion
• 374.10 Ectropion
• 375.51 Punctal eversion
• 375.52 Punctal stenosis
• 375.41 Canaliculitis
• 372.21 Angular Blepharoconjunctivitis
• 372.22 Contact blepharoconjunctivitis
• 373.01 Ulcerative blepharitis

Other codes may apply.

 

---

⁽¹⁾ For illustrative purposes only. Providers should follow coding conventions for diagnostic tests as well as payer instructions when selecting appropriate ICD-9-CM diagnosis codes. See Medicare Claims Processing Manual (Pub 100-4), Chapter 23, Section 10.1.

Disclaimer: The information provided on this website is current as of February 2011 and was obtained from third-party sources and is subject to change without notice as a result of changes in reimbursement laws, regulations, rules, policies, and payment amounts. All content on this website is informational only, general in nature, and does not cover all situations or all payers' rules and policies. This content is not intended to instruct hospitals and/or physicians on how to use or bill for healthcare procedures, including new technologies outside of Medicare national guidelines. A determination of medical necessity is a prerequisite that TearLab Corporation assumes will have been made prior to assigning codes or requesting payments.

Under Federal and State law, it is the individual provider's responsibility to determine appropriate coding, charges and claims for a particular service. Policies regarding appropriate coding and payment levels can vary greatly from payer to payer and change over time. TearLab Corporation recommends that providers contact their own regional payers to determine appropriate coding and charge or payment levels.

If you are a provider participating in a clinical trial, we recommend you contact your payers, including Medicare/Medicaid and private insurers, to verify correct coverage and reimbursement policies for investigational devices.

This website information represents no promise or guarantee by TearLab Corporation concerning coverage, coding, billing, and payment levels. TearLab Corporation specifically disclaims liability or responsibility for the results or consequences of any actions taken in reliance on information on this website.